Alpha DNA Investment Management’s Cross Country Healthcare CCRN Stock Holding History

Alpha DNA Investment Management’s Portfolio CCRN Stock Details CCRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-36,981	Closed	-$983K	–	157
2022 Q4	$983K	Buy	36,981 +18,772	+103%	+$613K	0.35%	132
2022 Q3	$516K	Sell	18,209 -31,189	-63%	-$802K	0.43%	127
2022 Q2	$1.03M	Sell	49,398 -5,453	-10%	-$102K	0.88%	42
2022 Q1	$1.19M	Buy	54,851 +271	+0.5%	+$5.88K	0.83%	74
2021 Q4	$1.51M	Sell	54,580 -13,223	-20%	-$321K	0.96%	67
2021 Q3	$1.44M	Buy	+67,803	New	+$1.27M	0.98%	42

Other funds holding CCRN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SCM

Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Alpha DNA Investment Management's CCRN Position: Q1 2023 in Review

Alpha DNA Investment Management sold out of Cross Country Healthcare (CCRN) in Q1 2023, closing a stake of 36,981 shares — an estimated $983K sold.

Alpha DNA Investment Management first reported a position in CCRN in Q3 2021 and held it in 6 quarters. The position peaked at $1.51M in Q4 2021. 201 funds tracked by Wall St. Rank hold CCRN as of Q1 2023.

Alpha DNA Investment Management reported no remaining Cross Country Healthcare position as of Q1 2023 after selling out during the quarter.
Alpha DNA Investment Management sold 36,981 Cross Country Healthcare shares in Q1 2023, an estimated $983K.
Alpha DNA Investment Management first reported a position in Cross Country Healthcare in Q3 2021 and held it in 6 quarters.
Alpha DNA Investment Management's Cross Country Healthcare position peaked at $1.51M in Q4 2021.
201 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2023.

Based on Alpha DNA Investment Management's 13F filing for Q1 2023, filed 5 May 2023.